Analysts Think Axsome Therapeutics Stock Could Soar 35% Over the Next 12 Months. Is the Stock a No-Brainer Buy? The Motley Fool 5d
Axsome Therapeutics vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool 6d
Axsome Therapeutics (AXSM) Unveils New Depression And Alzheimer’s Agitation Data At Psych Congress 2026 Simply Wall St 6d
Virtual biotech company puts 37,000 AI agents to work on drug discovery Singularity Hub 5d AI Biotech Pharma
Anixa Biosciences Granted First Australian Patent for its Breast Cancer Vaccine, Broadening Global Protection Through 2040 PR Newswire (Press Release) 3d Patent Law Intellectual Property Ohio
Bioshanghai week 2026 opens -- Joining forces to build a global biopharmaceutical innovation ecosystem PR Newswire (Press Release) 4d China Politics Biotech
Ultragenyx pharmaceutical (rare) stock jumps after hours: Here's why it is trending Benzinga 6d Pharma Article paywall
AstronauTx receives funding for Parkinson’s sleep research PharmaTimes 15h Parkinson's Disease Michael J. Fox Health
2 Stocks to Buy Hand Over Fist if a Stock Market Crash Is Coming The Motley Fool 16h The Coca-Cola Company Johnson and Johnson Oil & Gas
